Serum hepcidin in inflammatory bowel diseases: biological and clinical significance. (Q47980971)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Serum hepcidin in inflammatory bowel diseases: biological and clinical significance (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

5 March 2020

main subject

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Gaetano Bergamaschi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Gino R Corazza

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

3

Riccardo Albertini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

7

Alessandra Pasini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

5

Marco Guerci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

author name string

Filippo Costanzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Michela Masotti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Alessandro Massari

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Natascia Campostrini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Michela Corbella

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Domenico Girelli

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

publication date

1 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

5 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

2166-2172

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.

5 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Diagnosing anemia in inflammatory bowel disease: beyond the established markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Two to tango: regulation of Mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Hepcidin and iron regulation, 10 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Hepcidin and the iron-infection axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Dysregulated monocyte iron homeostasis and erythropoietin formation in patients with anemia of chronic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Hepcidin and inflammatory bowel disease: dual role in host defence and iron homoeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Severe iron deficiency blunts the response of the iron regulatory gene Hamp and pro-inflammatory cytokines to lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Pathways for the regulation of hepcidin expression in anemia of chronic disease and iron deficiency anemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Iron and intestinal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

The bone morphogenetic protein-hepcidin axis as a therapeutic target in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Antimicrobial activity of human hepcidin 20 and 25 against clinically relevant bacterial strains: effect of copper and acidic pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

Serum hepcidin: reference ranges and biochemical correlates in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FMIB.0B013E31829A6E43

10.1097/MIB.0B013E31829A6E43

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23867871%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference